Muscle Ultrasound Study in Shock Patients
Key facts
- Who runs it
- University Hospital, Geneva
- Where
- Switzerland1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 30 people enrolled
- Started
- 13 Oct 2020
- Ended
- 20 Aug 2024
- Type of study
- Observational
- Treatments tested
- Diaphragm ultrasound (DUS)
- Peripheral Muscle Ultrasound (PMUS)
- Airway occlusion pressure (P0.1)
- Medical Research Council (MRC) sum score
- Record updated
- 9 December 2024
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 19 criteriaShow less
Who can take part
- adult patients (> 18 years old) admitted to the ICU
- with a diagnosis of septic shock
- a SOFA score equal or superior to 8 points, at ICU admission
- blood lactate concentration above 2 mmol/L, at ICU admission
- expected to have more than 48h of mechanical ventilation (estimated by the attending physician)
- expected to stay more than 5 days in the unit (estimated by the attending physician)
- able to walk prior to ICU admission / walking aids accepted
Who cannot take part
- diagnosed neuromuscular or central nervous system diseases
- cancers derived sarcopenia
- anorexic disorders (protein-energy malnutrition)
- pregnancy
- lower limb amputation, fixators or open wounds
- thoracic fixators or open wounds
- being transferred from another ICU
- spinal cord injury
- diaphragm pacemaker
- palliative goals of care
- cachexia
- intellectual or cognitive impairments, limiting the ability to follow instructions
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
Intensive Care Unit (ICU) patients are known to lose muscle mass and function for many reasons, ranging from prolonged immobilization, to the effects of ICU treatments such as mechanical ventilation (MV), to the critical illness itself. Ultrasonography (US) is widely used in the ICU setting and has greatly evolved in the last decades, since it allows the non-invasive assessment of different structures, using radiation-free and user-friendly technology; its application for the assessment or the skeletal muscle is a promising tool and might help detecting muscle changes and thus several dysfunctions during early stages of ICU stay.
Read full original descriptionShow less
By using skeletal muscle ultrasound at both diaphragm and peripheral levels, the overall aim of this study is to improve knowledge in the early detection of muscle dysfunction and weakness , and their relationship with mechanical ventilation weaning and muscle strength, in critically ill patients suffering from septic shock.
The group in the trial
- Septic Shock
Treatment: Diaphragm ultrasound (DUS), Peripheral Muscle Ultrasound (PMUS), Airway occlusion pressure (P0.1), and Medical Research Council (MRC) sum score
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- Diaphragm Dysfunction and Peripheral Muscle Wasting in Septic Shock Patients: Exploring Their Relationship Over Time Using Ultrasound Technology
- Publications
- Record updated
- 9 December 2024